• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血容量对血清 PSA 水平有影响吗?

Has blood volume an impact on serum PSA levels?

机构信息

Department of Urology and Andrology, Donauspital, SMZ-Ost, Langobardenstrasse 122, 1220, Vienna, Austria.

出版信息

World J Urol. 2010 Dec;28(6):693-7. doi: 10.1007/s00345-009-0468-z. Epub 2009 Aug 27.

DOI:10.1007/s00345-009-0468-z
PMID:19711085
Abstract

PURPOSE

Prostate-specific antigen (PSA) is measured in circulating blood volume (BV), which is known to have a wide inter- and intraindividual variability. As data investigating the potential impact of different BV on PSA test validity are scant, we determined the relationship between BV and serum PSA values.

METHODS

Men aged 41-60 years, participating in a health screening project, were evaluated. Serum samples of fasting patients were drawn between 8.00 and 10.00 a.m., all PSA measurements were determined in the same laboratory. Circulating BV was calculated according to the Retzlaff formula based on height, weight and haematocrit.

RESULTS

A total of 400 men with a mean age of 47.9 years entered the analysis. Mean PSA was 1.20 ng/ml (range 0.23-8.59 ng/ml) and mean BV was 3,370 ml (range 2,380-4,220 ml). Mean PSA values stratified from lowest to the highest third of BV were 1.22, 1.17 and 1.19 ng/ml in the total cohort. The respective figures for men aged 41-50 years were 1.08, 0.98 and 1.03 ng/ml, and for those aged 51-60 years: 1.47, 1.48 and 1.53 ng/ml. Neither BV nor three other related biometrical parameters (body mass index, waist-hip ratio, body fat percentage) revealed a correlation with the PSA values.

CONCLUSION

Our data suggest that BV does not have a significant impact on serum PSA values. To exclude a potential minor impact of BV on PSA, larger study cohorts, however, are required.

摘要

目的

前列腺特异性抗原(PSA)在循环血量(BV)中进行测量,已知其具有广泛的个体间和个体内变异性。由于缺乏关于不同 BV 对 PSA 检测有效性潜在影响的数据,我们确定了 BV 与血清 PSA 值之间的关系。

方法

评估年龄在 41-60 岁之间参加健康筛查项目的男性。空腹患者的血清样本在 8.00 至 10.00 之间抽取,所有 PSA 测量均在同一家实验室进行。根据身高、体重和红细胞压积的 Retzlaff 公式计算循环 BV。

结果

共有 400 名年龄为 47.9 岁的男性进入分析。平均 PSA 为 1.20ng/ml(范围 0.23-8.59ng/ml),平均 BV 为 3370ml(范围 2380-4220ml)。根据 BV 从最低到最高三分之一分层的平均 PSA 值在总队列中分别为 1.22、1.17 和 1.19ng/ml。41-50 岁男性的相应数字分别为 1.08、0.98 和 1.03ng/ml,51-60 岁男性的相应数字分别为 1.47、1.48 和 1.53ng/ml。BV 及其他三个相关生物计量参数(体重指数、腰臀比、体脂百分比)均与 PSA 值无相关性。

结论

我们的数据表明,BV 对血清 PSA 值没有显著影响。为了排除 BV 对 PSA 可能产生的轻微影响,需要更大的研究队列。

相似文献

1
Has blood volume an impact on serum PSA levels?血容量对血清 PSA 水平有影响吗?
World J Urol. 2010 Dec;28(6):693-7. doi: 10.1007/s00345-009-0468-z. Epub 2009 Aug 27.
2
Body mass index in relation to prostate-specific antigen-related parameters.体重指数与前列腺特异性抗原相关参数的关系。
BMC Urol. 2021 Sep 16;21(1):130. doi: 10.1186/s12894-020-00746-8.
3
Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.经计算的快速增长型良性前列腺增生——一种发生临床前列腺癌的风险因素。
Scand J Urol Nephrol. 2002;36(5):330-8. doi: 10.1080/003655902320783827.
4
Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.前列腺增大部分掩盖了代谢综合征对血清前列腺特异性抗原水平的实际降低作用:一项基于大规模人群研究的结果
BJU Int. 2017 Oct;120(4):482-489. doi: 10.1111/bju.13621. Epub 2016 Aug 28.
5
Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population.在明确界定的患者群体中,90天内重复血清前列腺特异性抗原(PSA)测量值的变异性。
Urology. 1996 Jan;47(1):59-66. doi: 10.1016/s0090-4295(99)80383-5.
6
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.血清前列腺特异性抗原作为良性前列腺增生男性前列腺体积的预测指标。
Urology. 1999 Mar;53(3):581-9. doi: 10.1016/s0090-4295(98)00655-4.
7
Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.前列腺特异性抗原(PSA)质量比值在 PSA 水平≤10ng/ml 男性前列腺癌检测中的价值。
BJU Int. 2012 Jul;110(2 Pt 2):E81-5. doi: 10.1111/j.1464-410X.2011.10764.x. Epub 2011 Nov 17.
8
Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population.
Urology. 1996 Mar;47(3):343-6. doi: 10.1016/s0090-4295(99)80450-6.
9
Body mass index and prostate specific antigen levels in Jamaican men.牙买加男性的体重指数与前列腺特异性抗原水平
West Indian Med J. 2011 Jun;60(3):316-21.
10
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.基于社区的健康男性人群中的血清前列腺特异性抗原。特定年龄参考范围的建立。
JAMA. 1993 Aug 18;270(7):860-4.

引用本文的文献

1
Age-specific PCA3 score reference values for diagnosis of prostate cancer.前列腺癌诊断用年龄特异性 PCA3 评分参考值。
World J Urol. 2012 Jun;30(3):405-10. doi: 10.1007/s00345-011-0749-1. Epub 2011 Aug 30.

本文引用的文献

1
Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.在前列腺、肺、结肠直肠和卵巢癌筛查试验中接受筛查的肥胖男性血清前列腺特异性抗原的血液稀释情况。
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):748-51. doi: 10.1158/1055-9965.EPI-08-0938. Epub 2009 Mar 3.
2
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.前列腺癌男性患者中与肥胖相关的血浆血液稀释及前列腺特异性抗原浓度
JAMA. 2007 Nov 21;298(19):2275-80. doi: 10.1001/jama.298.19.2275.
3
Update on PSA testing.
前列腺特异性抗原检测的最新情况。
J Natl Compr Canc Netw. 2007 Aug;5(7):737-42. doi: 10.6004/jnccn.2007.0065.
4
Prostate-specific antigen in clinical practice.临床实践中的前列腺特异性抗原
Cancer Lett. 2007 Apr 28;249(1):30-9. doi: 10.1016/j.canlet.2006.12.022. Epub 2007 Jan 26.
5
Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.2001年至2004年期间,在美国男性中,肥胖与前列腺特异性抗原呈负相关。
Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):70-6. doi: 10.1158/1055-9965.EPI-06-0588. Epub 2006 Dec 19.
6
Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.肥胖和身高对非裔美国男性和白人男性前列腺特异性抗原(PSA)及游离PSA水平百分比的影响。
Cancer. 2006 Nov 15;107(10):2361-7. doi: 10.1002/cncr.22249.
7
Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.肥胖、血清前列腺特异性抗原与前列腺大小:对前列腺癌检测的影响
J Urol. 2006 Feb;175(2):500-4; discussion 504. doi: 10.1016/S0022-5347(05)00162-X.
8
Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.年龄和体重指数对总前列腺特异性抗原及复合前列腺特异性抗原的观察效应:来自一项全国性筛查项目的分析
Urology. 2005 Apr;65(4):708-12. doi: 10.1016/j.urology.2004.10.074.
9
The association of body mass index and prostate-specific antigen in a population-based study.一项基于人群的研究中体重指数与前列腺特异性抗原的关联。
Cancer. 2005 Mar 1;103(5):1092-5. doi: 10.1002/cncr.20856.
10
Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men.年龄、人体测量学指标以及肝肾功能对健康中年男性血清前列腺特异性抗原水平的影响。
Urology. 2003 Jan;61(1):132-6. doi: 10.1016/s0090-4295(02)02001-0.